Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Non-Small-Cell Lung × spartalizumab × Clear all

Phase

Phase 1 10 Phase 2 7 Phase 1/2 3 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Epstein-Barr Virus Infections 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 9 Cisplatin 8 Carboplatin 6 icotinib 5 Gefitinib 5 Erlotinib Hydrochloride 5 Docetaxel 5 endostar protein 3 Zoledronic Acid 3 Radiotherapy 3 Paclitaxel 3 Endostatins 3 Afatinib 3 tislelizumab 2 pembrolizumab 2 osimertinib 2 Vinorelbine 2 Surgical Procedures, Operative 2 Gemcitabine 2 Chemoradiotherapy 2 trametinib 1 spartalizumab 1 sotorasib 1 pegfilgrastim 1 lorlatinib 1 flurbiprofen axetil 1 elemene 1 durvalumab 1 dexamethasone 21-phosphate 1 dacomitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06357598 2024-04-10

PILOT

The Affiliated Hospital of Qingdao University

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡